Baxter International Inc.· BAX
🇺🇸 US · LargeSP500NYSE
- Price
- $28.35
- Day
- +0.89%
- Mkt Cap
- $14.66B
- 52W Range
- $15.73 – $30.00
- Volume
- 9.84M
- Beta
- 0.61
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has commenced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the maximum principal amount of validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”), such that the aggregate purchase price, not including accrued and unpaid interest, payable in respect of such Notes will not exceed $500 million. The terms and c.
Read full article
Baxter International has shown early signs of a turnaround, with improving execution and raised revenue guidance supporting cautious optimism. BAX's valuation has expanded from distressed levels, now trading at ~13x earnings and ~9.5x EV/EBITDA, yet remains attractive if growth continues. Management's focus on operational improvements, cost savings, and a conservative outlook suggests potential for further upside if EPS growth materializes.
Read full article
On August 03, 2026, Baxter International Inc (BAX) shares rose 7.4% today, bringing the current price to $28.10. The stock has shown significant price performan
Read full article
It scored double beats on analyst estimates. It also lifted its guidance on both the top and bottom lines.
Read full article
On July 30, 2026, Baxter International Inc (BAX) shares rose 8.0%, closing at $26.75. This increase comes amidst a volatile 52-week range, with shares oscillati
Read full article
Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.
Read full article
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read full article
Baxter International (BAX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.59 per share a year ago.
Read full article
Medical products maker Baxter International on Thursday raised its annual profit forecast and beat Wall Street estimates for quarterly results, banking on robust sales of its medical products such as IV solutions.
Read full article
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026. “Our second-quarter results exceeded expectations on both the top and bottom lines, driven by both operating performance and an additional benefit from a tariff refund that was not previously contemplated in our guidance,” said Andrew Hider, president and CEO. “While we're encouraged by this steady progress and core operating momentum, we remain.
Read full article
Baxter International Inc. (NYSE:BAX) stock is trading higher on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2026 guidance.
Read full article
Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript
Read full article